Gujarat Themis Biosyn informs about closure of trading window

26 Dec 2022 Evaluate
Gujarat Themis Biosyn has informed that as per the Company's minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) (SEBI (PIT) Regulations) and pursuant to BSE Circular Ref No: LIST/COMP/01/2019-20 dated 2nd April, 2019 on the provisions of Clause 4 of the Schedule B of SEBI (PIT) Regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from Sunday 1st January, 2023 and will re-open after completion of 48 hours from the declaration of financial results for the quarter and nine months ended 31.12. 2022 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter and nine months ended 31.12.2022 shall be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

404.75 -2.90 (-0.71%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.